Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Article Type
Facet Toggle
Time Frame
Facet Toggle
Dec
7
2021
9:00—10:30 AM Eastern Time (US and Canada)
November 23, 2021
The COVID-19 pandemic is a critical care crisis. Many lives have been lost during the pandemic while countries tried to scale up ventilators and other high-cost critical care services, at times overlooking effective yet low-cost essential emergency and critical care (EECC) practices.
Nov
30
2021
9:00—10:15 AM Eastern Time (US and Canada)
November 17, 2021
Ineffective and inefficient registration processes impede access to lifesaving, quality-assured essential medicines. As a result of inadequate legal provisions, limited capacity within National Regulatory Authorities, and long and unpredictable registration processes as well as low profit margins an...
Blog Post
November 12, 2021
Obviously, an ethical vaccine distribution would start with a far more equitable sharing of vaccines between rich and less-rich nations. More pragmatically, the current huge imbalance in the global distribution of shots invites another outbreak of a new variant, against which the US and other high-i...
Blog Post
October 28, 2021
We conducted a joint review of the portfolio management activities of the committee overseeing COVAX R&D and manufacturing investments, known as RDMIC (R&D and Manufacturing Investment Committee). Our aim was to assess learnings from investments to date and suggest ways to strengthen future ...
Nov
4
2021
11:00—12:00 PM Eastern Time (US and Canada)
October 27, 2021
After earlier calls for transparency in the global deployment of COVID-19 vaccine, we’ve seen progress: in addition to UNICEF’s COVID-19 Vaccine Dashboard launched in December 2020, the Task Force on COVID-19 Vaccines, Therapeutics, and Diagnostics – launched in June 2021 – houses a central reposito...
Blog Post
October 21, 2021
After buying up the World’s vaccine supply to ensure they can protect their own populations, rich countries have found themselves struggling to use the vaccine surpluses they accumulated. One response has been to donate the spare doses to countries who need them more. This is laudable, and countries...
Blog Post
October 21, 2021
Poor understanding about vaccine capacity was one of the reasons why the world did not have the infrastructure needed to manufacture sufficient doses. This blogs proposes three actions to start tracking manufacturing capacity better and create robust estimates for the world’s vac...
Blog Post
October 06, 2021
Anyone who follows the media on development finance will not be surprised if the corridor talk at the upcoming Annual Meetings of the World Bank and International Monetary Fund (IMF) is affected by the recent World Bank decision to discontinue the Doing Business Index. These discussions will invaria...